Verona Pharma plc (VRNA) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Blavatnik Len con 55,911,648 acciones. Otros tenedores destacados incluyen Access Industries Holdings LLC y ZACCARDELLI DAVID.
En los últimos 12 meses, los internos han realizado 40 transacciones en VRNA acciones — 16 compras (valoradas en $431.64K) y 15 ventas (valoradas en $26.87M). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
VRNA Participación de Insiders
Principal Titular
Blavatnik Len
55,911,648 acciones
Compras (12 meses)
16
$431.64K valor
Ventas (12 meses)
15
$26.87M valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Blavatnik Len |
Director |
55,911,648 |
2022-08-17 |
|
| 2 |
Access Industries Holdings Llc |
10 Percent Owner |
51,111,648 |
2022-08-17 |
|
| 3 |
Zaccardelli David |
President and CEO |
13,190,168 |
2025-06-13 |
|
| 4 |
Hahn Mark W |
Chief Financial Officer |
12,278,992 |
2025-06-13 |
|
| 5 |
Makhzoumi Mohamad |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 6 |
Baskett Forest |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 7 |
Florence Anthony A. Jr. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 8 |
Sandell Scott D |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 9 |
Makower Joshua |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 10 |
Sonsini Peter W. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 11 |
Gupta Rishi |
Director |
4,180,691 |
2023-05-15 |
|
| 12 |
Orbimed Advisors Llc |
Director |
4,180,691 |
2023-05-15 |
|
| 13 |
Rickard Kathleen A. |
Chief Medical Officer |
2,546,472 |
2025-05-08 |
|
| 14 |
Poll Claire |
General Counsel |
1,176,920 |
2024-02-05 |
|
| 15 |
Fisher Andrew |
General Counsel |
439,999 |
2025-06-18 |
|
| 16 |
Shah Mahendra |
Director |
96,000 |
2025-04-29 |
|
| 17 |
Edwards Martin |
Director |
96,000 |
2025-04-29 |
|
| 18 |
Cunningham Kenneth |
Director |
96,000 |
2025-04-29 |
|
| 19 |
Ebsworth David R |
Director |
96,000 |
2025-04-29 |
|
| 20 |
Ullman Anders |
Director |
96,000 |
2025-04-29 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2025-06-16 |
Fisher Andrew |
General Counsel |
Venta Informativa |
80,000 |
$11.53 |
$922K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Ejercicio de Opciones |
80,000 |
$2.01 |
$160.9K |
| 2025-06-11 |
Zaccardelli David |
President and CEO |
Venta Informativa |
400,000 |
$11.40 |
$4.56M |
| 2025-06-11 |
Hahn Mark W |
Chief Financial Officer |
Venta Informativa |
400,000 |
$11.40 |
$4.56M |
| 2025-05-29 |
Zaccardelli David |
President and CEO |
Venta Informativa |
208,696 |
$9.33 |
$1.95M |
| 2025-05-28 |
Zaccardelli David |
President and CEO |
Venta Informativa |
157,704 |
$9.30 |
$1.47M |
| 2025-05-27 |
Zaccardelli David |
President and CEO |
Venta Informativa |
33,600 |
$9.53 |
$320.18K |
| 2025-05-29 |
Hahn Mark W |
Chief Financial Officer |
Venta Informativa |
204,864 |
$9.33 |
$1.91M |
| 2025-05-28 |
Hahn Mark W |
Chief Financial Officer |
Venta Informativa |
162,704 |
$9.30 |
$1.51M |
| 2025-05-27 |
Hahn Mark W |
Chief Financial Officer |
Venta Informativa |
32,432 |
$9.53 |
$308.98K |
| 2025-05-20 |
Sinha Vikas |
Director |
Ejercicio de Opciones (Venta) |
160,000 |
$0.50 |
$80.61K |
| 2025-04-29 |
Sinha Vikas |
Director |
Ejercicio de Opciones (Venta) |
120,384 |
$1.70 |
$204.65K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Venta Informativa |
80,000 |
$8.57 |
$685.6K |
| 2025-05-14 |
Ackermann Christina |
Director |
Venta Informativa |
40,000 |
$8.44 |
$337.6K |
| 2025-05-06 |
Rickard Kathleen A. |
Chief Medical Officer |
Venta Informativa |
114,984 |
$8.82 |
$1.01M |
| 2025-05-01 |
Rickard Kathleen A. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
50,000 |
- |
- |
| 2025-05-02 |
Zaccardelli David |
President and CEO |
Venta Informativa |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Zaccardelli David |
President and CEO |
Ejercicio de Opciones (Venta) |
200,000 |
- |
- |
| 2025-05-02 |
Hahn Mark W |
Chief Financial Officer |
Venta Informativa |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Hahn Mark W |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
200,000 |
- |
- |
| 2025-05-01 |
Ebsworth David R |
Director |
Ejercicio de Opciones |
140,000 |
$1.93 |
$270.73K |
| 2025-04-29 |
Fisher Andrew |
General Counsel |
Ejercicio de Opciones (Venta) |
86,064 |
- |
- |
| 2025-03-19 |
Fisher Andrew |
General Counsel |
Donación (Recibida) |
1 |
- |
- |
| 2025-04-29 |
Rickard Kathleen A. |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
86,064 |
- |
- |
| 2024-08-07 |
Rickard Kathleen A. |
Chief Medical Officer |
Concesión de RSU |
300,000 |
- |
- |
